SentiAR

Jon created the SentiAR visualization platform and has oversight for the overall technical design and development to meet current and future clinical applications. It was his original work that secured over $500,000 in grants to build the initial prototype on the Microsoft Hololens platform for in-human engineering trials. As an Asst. Professor of Biomedical Engineering at Washington University in St. Louis, his research laboratory specializes in applying computational approaches to address problems in cardiac electrophysiology. Jonathan is part of the Cardiac Bioelectricity and Arrhythmia Center, and his academic preparation includes a BS from Johns Hopkins University, an MS from Case Western Reserve University, and a PhD in Biomedical Engineering, Washington University.

Jennifer Avari Silva is responsible for the clinical application of the SentiAR technology for patient use. She is an Asst. Professor of Pediatrics at Washington University in St. Louis and Director of Pediatric Cardiac Electrophysiology at St. Louis Children’s Hospital, where she leads the largest pediatric electrophysiology program in the Midwest. Dr. Avari Silva has published numerous papers bringing new technologies to pediatric patients, allowing her to develop an extensive industrial network with companies that include, St. Jude Medical, Medtronic, Biotronik, and Biosense Webster.

Michael is responsible for the company’s holographic platform validation, software planning, and team execution. Prior to joining the project, he developed 3D computer vision exploitation of sensor data for use in airborne platforms as an electrophysics scientist at Boeing Research and Technology. From 2007-2015 at the Johns Hopkins University Applied Physics Laboratory (JHUAPL), Michael specialized in the rapid development of embedded systems for direct deployment to the Department of Defense end users, primarily focused on the technical integration of wireless embedded systems with emerging microelectromechanical systems (MEMS) sensor technology, navigation, electro-optical sensor development and 3D sensor exploitation. Michael earned his BS from UC Berkeley and a dual MS from Johns Hopkins University.

Berk Tas serves as the Chief Executive Officer and President of SentiAR. Berk has led development of emerging technologies and companies in Fortune 500, private equity, venture capital funded and privately held organizations. Prior to joining SentiAR he led the development of a novel Trans-aortic Valve Replacement technology into CE Mark studies at HLT Medical. In 2016, he played an integral role in the acquisition of Sensium, Oxford UK, a novel wireless monitoring technology. Prior to that he served in various leadership roles at Sunshine Heart developing a first of its kind, heart failure therapy and at Boston Scientific developing several novel therapies and technologies focused in Cardiac Rhythm Management. He holds an MBA from the Carlson School of Business at the University of Minnesota and a BS in Electrical Engineering and Physics from the School of Engineering at St Thomas University.